Related content

Clinical Impact of 18F-FDG-PET in the Suspicion of Recurrent Ovarian Carcinoma Based on Elevated Tumor Marker Serum Levels

By Jimenez-Bonilla J.   Maldonado A.   Morales S.   Salud A.   Zomeno M.   Roman J.   Belon J.   Moya F.  

Clinical Positron Imaging, Vol. 3, Iss. 6, 2000-11 ,pp. : 231-236

Elsevier

Access to resources Recommend Favorite

Clinical use of ¹¹C-methionine and ¹⁸F-FDG-PET for germinoma in central nervous system

By Okochi Yoshiyuki   Nihashi Takashi   Fujii Masazumi   Kato Katsuhiko   Okada Yumiko   Ando Yoshio   Maesawa Satoshi   Takebayashi Shigenori   Wakabayashi Toshihiko   Naganawa Shinji  

Annals of Nuclear Medicine, Vol. 28, Iss. 2, 2014-02 ,pp. : 94-102

Springer Publishing Company

Access to resources Recommend Favorite

18F-FDG-PET zur Therapieverlaufskontrolle beim Ösophaguskarzinom

By Wieder H.A.   Herrmann K.   Krause B.J.  

Der Radiologe, Vol. 47, Iss. 2, 2007-02 ,pp. : 110-114

Springer Publishing Company

Access to resources Recommend Favorite

Phase analysis by gated F-18 FDG PET/CT for left ventricular dyssynchrony assessment: a comparison with gated Tc-99m sestamibi SPECT

By Wang Li   Wei Hong-Xing   Yang Min-Fu   Guo Jin   Wang Jian-Feng   Fang Wei   Wang Yue-Tao  

Annals of Nuclear Medicine, Vol. 27, Iss. 4, 2013-05 ,pp. : 325-334

Springer Publishing Company

Access to resources Recommend Favorite

Role of [¹⁸F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings

By Chung Hyun   Kang Won   Kim Jae   Park Noh-Hyun   Song Yong-Sang   Chung June-Key   Kang Soon-Beom   Lee Hyo-Pyo  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 4, 2007-04 ,pp. : 480-486

Springer Publishing Company

Access to resources Recommend Favorite